The Harris Lab uses a large repertoire of model systems and experimental approaches to understand how DNA mutating enzymes (APOBECs) provide immunity against viral infections, yet in many cases also contribute to tumor evolution through genomic DNA mutagenesis. Another goal of the Harris Lab is to translate these fundamental scientific discoveries into novel therapeutics against viruses and cancer.
October 1, 2015
The Harris Lab welcomes two new postdoctoral research associates to our group, Catherine Waters and Dan Salamango.
September 12, 2015
The Harris Lab participated in the MOCA event, HOM Teal Strides for Ovarian Cancer.
September 1, 2015
Dr. Reuben Harris becomes HHMI investigator (HHMI announcement, UMN announcement).